Hims & Hers Health PE Ratio 2020-2025 | HIMS
Current and historical p/e ratio for Hims & Hers Health (HIMS) from 2020 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hims & Hers Health PE ratio as of May 08, 2025 is 121.74.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Hims & Hers Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-08 | 51.40 | 104.90 | |
| 2025-03-31 | 29.55 | $0.49 | 60.31 |
| 2024-12-31 | 24.18 | $0.54 | 44.78 |
| 2024-09-30 | 18.42 | $0.44 | 41.86 |
| 2024-06-30 | 20.19 | $0.08 | 252.38 |
| 2024-03-31 | 15.47 | $-0.01 | 0.00 |
| 2023-12-31 | 8.90 | $-0.11 | 0.00 |
| 2023-09-30 | 6.29 | $-0.17 | 0.00 |
| 2023-06-30 | 9.40 | $-0.22 | 0.00 |
| 2023-03-31 | 9.92 | $-0.29 | 0.00 |
| 2022-12-31 | 6.41 | $-0.32 | 0.00 |
| 2022-09-30 | 5.58 | $-0.42 | 0.00 |
| 2022-06-30 | 4.53 | $-0.41 | 0.00 |
| 2022-03-31 | 5.33 | $-0.36 | 0.00 |
| 2021-12-31 | 6.55 | $-0.62 | 0.00 |
| 2021-09-30 | 7.54 | $-0.54 | 0.00 |
| 2021-06-30 | 10.89 | $-0.46 | 0.00 |
| 2021-03-31 | 13.23 | $-0.41 | 0.00 |
| 2020-12-31 | 14.60 | $-0.07 | 0.00 |
| 2020-09-30 | 11.75 | 0 | 0.00 |
| 2020-06-30 | 10.17 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.630B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.774B | 53.56 |
| Tempus AI (TEM) | United States | $10.119B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.616B | 72.12 |
| IRhythm Technologies (IRTC) | United States | $4.348B | 0.00 |
| Privia Health (PRVA) | United States | $2.829B | 212.00 |
| Enovis (ENOV) | United States | $1.955B | 12.10 |
| Clover Health Investments (CLOV) | United States | $1.926B | 0.00 |
| Schrodinger (SDGR) | United States | $1.732B | 0.00 |
| Phreesia (PHR) | United States | $1.434B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.74 |
| Omnicell (OMCL) | United States | $1.154B | 20.35 |
| 10x Genomics (TXG) | United States | $1.016B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.568B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.530B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.387B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 850.00 |
| Claritev (CTEV) | United States | $0.344B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.279B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.215B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.148B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.081B | 0.00 |
| CareCloud (CCLD) | United States | $0.080B | 3.03 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.042B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |